Titrzepatide reduces risk of death or worsening heart failure for patients with obesity-related heart failure

Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with heart failure, preserved heart pump function and obesity, new research from UVA Health reveals.

Medartis 2023 half-year results presentation – Biotech Investments

Medartis Holding AG / Key word(s): Half Year Results Medartis 2023 half-year results presentation 25.07.2023 / 09:00 CET/CEST INVITATION │ AUDIO WEBCAST We are pleased

July 26, 2023

Study links stress to metabolic syndrome, highlights inflammation’s role

New research links stress to metabolic syndrome through inflammation, suggesting stress management as a potential strategy for improving biological health outcomes.

January 14, 2024

Apple Launches AirPods Pro 2: All-in-One Hearing Health Experience

What You Should Know: – Apple has introduced a groundbreaking new feature for AirPods Pro 2: the world’s first end-to-end hearing health experience. – The

September 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.